Feasibility of Postoperative Radiotherapy Using Conventional Fractionation for Lymph Node Metastasis from Cutaneous Melanoma

Anticancer Res. 2017 Aug;37(8):4239-4246. doi: 10.21873/anticanres.11816.

Abstract

Aim: In the present study we assessed if postoperative radiotherapy (PORT) using conventional fractionation confers a benefit in cutaneous melanoma patients with lymph node (LN) metastasis.

Patients and methods: Sixty-two patients with axillary or inguinal LN metastasis were retrospectively reviewed. Twenty-eight patients received PORT. The median RT dose was 50 Gy in 25 fractions. The high-risk group was defined by the presence of any of the following: ≥3 LNs, size ≥3 cm, extranodal extension.

Results: The median follow-up time was 34 months. PORT showed a significant benefit on 5-year axilla-inguinal recurrence-free survival (RFS) in high-risk patients (RT 100% vs. No-RT 37%, p=0.001). There was also a benefit of RT on 5-year out-field RFS in the high-risk population (RT 93% vs. No-RT 29%, p=0.002). There were no ≥grade 2 lymphedemas after RT.

Conclusion: PORT using conventional fractionation for high-risk LN metastasis from cutaneous melanoma is feasible with comparable regional control and minimal toxicity.

Keywords: Melanoma; lymphatic metastasis; postoperative radiotherapy.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Disease-Free Survival
  • Dose Fractionation, Radiation
  • Female
  • Humans
  • Lymph Nodes / pathology
  • Lymph Nodes / radiation effects
  • Lymph Nodes / surgery
  • Lymphatic Metastasis / pathology
  • Lymphatic Metastasis / radiotherapy*
  • Male
  • Melanoma / pathology
  • Melanoma / radiotherapy*
  • Melanoma / surgery
  • Melanoma, Cutaneous Malignant
  • Middle Aged
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / radiotherapy*
  • Postoperative Care
  • Radiotherapy, Adjuvant / adverse effects*
  • Skin Neoplasms / pathology
  • Skin Neoplasms / radiotherapy*
  • Skin Neoplasms / surgery
  • Treatment Outcome